AKT1 and breast cancer: The highly expressed Her-2 in Her-2 positive breast cancer is a kind of receptor tyrosine kinase (RTK), which mainly activates downstream signaling pathways such as PI3K-Akt and RAS-MAPK through heterogeneous dimerization with other kinds of RTK [13].